Jump to Main Content
A comparative study on the effect of argan oil versus fish oil on risk factors for cardio-vascular disease in high-fat-fed rats
- Haimeur, Adil, Meskini, Nadia, Mimouni, Virginie, Ulmann, Lionel, Messaouri, Hafida, Pineau-Vincent, Fabienne, Abouakil, Nezha, Tremblin, Gérard
- Nutrition 2019 v.57 pp. 32-39
- adiposity, antioxidant activity, blood lipids, blood platelets, cardiovascular diseases, dietary supplements, fish oils, high fat diet, hyperlipidemia, insulin resistance, liver, males, oxidative stress, platelet aggregation, polyunsaturated fatty acids, rats, risk factors, tissues
- The aim of this study was to investigate the effects of two different sources of polyunsaturated fatty acid—fish oil (FO) and argan oil (AO)—on some risk factors for cardiovascular disease, such as platelet aggregation, dyslipidemia, and oxidative stress.To explore this, four groups of six male rats were fed with different diets: The first group received a standard diet (control); the second group received a high-fat diet; the third was fed with a high-fat diet supplemented with 5% FO, and the last group received a high-fat diet supplemented with 5% AO.After 8 wk of the diet, AO showed a decrease in plasma lipids similar to that of FO. However, unlike FO, AO had no significant effect on hepatic lipid levels. On the other hand, supplementation with AO and FO similarly reduced platelet hyperactivity induced by high-fat diet. Concerning the results of oxidative stress, AO showed an antioxidant effect in the tissues and platelets greater than that observed in the high-fat FO group.For rats, the consumption of FO prevented the development of adiposity, restored insulin sensitivity, decreased plasma and liver lipid levels, and also prevented the prothrombotic effect. Intake of AO as a food supplement did not affect adiposity or liver lipid levels but decreased plasma lipid levels and improved oxidative status and platelet activity. FO and, to a lesser degree, AO thus represent promising nutritional tools in the prevention of cardiovascular disease.